Chengdu Olymvax Biopharmaceuticals Inc. Class ASSE: 688319

"Chengdu Olymvax Biopharmaceuticals Inc."Announcement on Voluntary Disclosure of Winning the Second Prize of the 2025 National Technological Invention Award

Jul 9, 2026 · Issued by Chengdu Olymvax Biopharmaceuticals Inc. Class A via Shanghai Stock Exchange

Announcement on Voluntary Disclosure of Winning the Second Prize of the 2025 National Technological Invention Award

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Chengdu Olymvax Biopharmaceuticals Inc. Class A

"Chengdu Olymvax Biopharmaceuticals Inc."Announcement on Receiving Government SubsidiesJul 1
Announcement on the Implementation of Repurchase and Cancellation of the Class A Restricted Shares Initially Granted under the 2023 Restricted Stock Incentive PlanJun 23
Announcement on Tax Payment RemediationJun 22
Announcement on Pledge of Some Shares Held by Shareholder with Over 5% SharesJun 12

All Chengdu Olymvax Biopharmaceuticals Inc. Class A news releases